N/A
N=15
Evaluation of Hearing Aid Benefit
Hearing Loss, Sensorineural
Bottom Line
View on ClinicalTrials.gov: NCT05198713 ↗Enrolled (actual)
15
Serious AEs
0.0%
Results posted
Jun 2023
Primary outcome: Primary: Speech Intelligibility in Quiet. — 92.3; 90.6 percentage of correct responses
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- New hearing aid (Device)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Sonova AG
- Primary completion
- Mar 2022
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Speech Intelligibility in Quiet. |
92.3; 90.6 | — |
| SECONDARY Speech Intelligibility in Noise, Expressed as the Signal to Noise Ratio at Which Participant Can Correctly Repeat 50% of the Words |
-9.83; -5.87 | <0.001 sig |
Summary
The present study will investigate the benefit of hearing aids for speech intelligibility (in both quiet and noisy environments) compared to the unaided condition. Participants will include adults with moderate to moderately severe hearing impairment. The participants will complete laboratory-based speech intelligibility assessments with binaural hearing aids and without hearing aids.
Eligibility Criteria
Inclusion Criteria
- Moderate to moderately severe sensorineural hearing loss
- Willingness to wear custom hearing instruments during the study.
- Age-normal cognition
- Ability to attend on-site study visits.
Data sourced from ClinicalTrials.gov (NCT05198713). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.